MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Surmodics, Inc.

< Previous 1 2 Next >
News headline image
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Participate in Upcoming Investor Conferences in August
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Participate in the Jefferies Healthcare Conference on June 8
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Participate in Upcoming Investor Conferences in March
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Host Virtual Annual Meeting of Shareholders
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
News headline image
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
From Surmodics, Inc.
Via Business Wire
Tickers SRDX
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story